HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $21 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Aura Biosciences, maintaining a price target of $21. This suggests confidence in the company's future performance.
September 13, 2024 | 10:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Aura Biosciences, maintaining a $21 price target. This indicates a positive outlook from the analyst, potentially boosting investor confidence.
The reiteration of a Buy rating and maintenance of a $21 price target by HC Wainwright & Co. suggests a positive outlook for Aura Biosciences. This can lead to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100